Paul L R Mitchell

Credit Name
Paul L R Mitchell
Full Name
Mitchell, Paul L R
 
 
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Rivalland, Gareth

Results 1-6 of 6 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1May-2022Loss of STING expression is prognostic in non-small cell lung cancer.Lohinai, Zoltan; Dora, David; Caldwell, Charles; Rivard, Christopher J; Suda, Kenichi; Yu, Hui; Rivalland, Gareth; Ellison, Kim; Rozeboom, Leslie; Dziadziuszko, Rafal; Mitchell, Paul L R ; John, Thomas ; Millan, Inigo S; Ren, Shengxiang; Hirsch, Fred R
2Aug-2020NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.Leal, Jose Luis; Peters, Geoffrey; Szaumkessel, Marcin; Leong, Trishe Y-M; Asadi, Khashayar ; Rivalland, Gareth; Do, Hongdo; Senko, Clare ; Mitchell, Paul L R ; Quing, Chai Zi; Dobrovic, Alexander ; Thapa, Bibhusal ; John, Thomas 
3Apr-2019Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas 
4Nov-2018The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.Ren, Shengxiang; Tian, Qinrui; Amar, Nadav; Yu, Hui; Rivard, Christopher J; Caldwell, Charles; Ng, Terry L; Tu, Megan; Liu, Yiwei; Gao, Dexiang; Ellison, Kim; Suda, Kenichi; Rozeboom, Leslie; Rivalland, Gareth; Mitchell, Paul L R ; Zhou, Caicun; Hirsch, Fred R
5Jul-2016Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.Rivalland, Gareth; Mitchell, Paul L R 
62015Update on Mucin-1 immunotherapy in cancer: a clinical perspectiveRivalland, Gareth; Loveland, Bruce E; Mitchell, Paul L R